TITANIUM HEALING CAPS
Device Facts
| Record ID | K960634 |
|---|---|
| Device Name | TITANIUM HEALING CAPS |
| Applicant | The Straumann Co. |
| Product Code | DZE · Dental |
| Decision Date | Jun 18, 1996 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 872.3640 |
| Device Class | Class 2 |
Intended Use
The esthetic healing caps are intended to protect the inner configuration of the III implant and the outer 45° shoulder of the implant during the healing phase after implant placement. The esthetic healing cap also serves to maintain, form, and stabilize the soft tissue during the healing phase. The primary indication for the esthetic healing cap is in the intra-oral esthetic zone where soft tissue conditioning is essential to achieve optimal esthetic results with implant-borne restorations.
Device Story
Titanium healing caps designed for use with ITI dental implants; placed during post-surgical healing phase (6-12 weeks). Device protects implant inner configuration and 45° shoulder; maintains, forms, and stabilizes soft tissue in esthetic oral zones. Features a bevel for labial/buccal positioning to allow tension-free mucoperiosteal flap closure. Operated by dentists/oral surgeons in clinical settings. Output is physical tissue support and protection of implant components; aids clinician in achieving optimal esthetic results for subsequent restorations.
Clinical Evidence
Bench testing only. No clinical data provided.
Technological Characteristics
Composed of commercially pure Grade 4 titanium (ASTM F67-95). Two-part design: healing cap body and occlusal screw. Available in 2.0 mm and 3.5 mm heights. Beveled design for soft tissue flap management. Non-software device.
Indications for Use
Indicated for patients requiring dental implant soft tissue conditioning in the intra-oral esthetic zone to facilitate optimal esthetic outcomes with implant-borne restorations during the 6-12 week post-implant healing phase.
Regulatory Classification
Identification
An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.
Special Controls
*Classification.* (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2) *Classification.* Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use; (ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads; (iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system; (iv) The device must be demonstrated to be biocompatible; (v) Sterility testing must demonstrate the sterility of the device; (vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment; (vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians; (viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and (ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.
Predicate Devices
- ITI Large Closure Screw
- Brånemark Healing Abutments
- Steri-Oss Healing Abutments
- Implant Innovations' Healing Abutments
Related Devices
- K962023 — PLASTIC PROTECTION HEALING CAPS · The Straumann Co. · Aug 15, 1996
- K190654 — Straumann CI RD Ceramic Healing Caps · Institut Straumann AG · Jun 28, 2019
- K192893 — Straumann Ceramic Healing Abutments · Institut Straumann AG · Jan 3, 2020
- K210826 — Healing Abutment, Cover Screw · Megagen Implant Co., Ltd. · Feb 3, 2022
- K171142 — Healing Cap Multi-Unit Titanium · Nobel Biocare AB · Oct 26, 2017